Y. E. Eksi Et Al. , "Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology," WORLD JOURNAL OF STEM CELLS , vol.13, no.6, pp.485-502, 2021
Eksi, Y. E. Et Al. 2021. Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology. WORLD JOURNAL OF STEM CELLS , vol.13, no.6 , 485-502.
Eksi, Y. E., ŞANLIOĞLU, A. D., AKKAYA, B., Ozturk, B. E., & ŞANLIOĞLU, S., (2021). Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology. WORLD JOURNAL OF STEM CELLS , vol.13, no.6, 485-502.
Eksi, Yunus Et Al. "Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology," WORLD JOURNAL OF STEM CELLS , vol.13, no.6, 485-502, 2021
Eksi, Yunus E. Et Al. "Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology." WORLD JOURNAL OF STEM CELLS , vol.13, no.6, pp.485-502, 2021
Eksi, Y. E. Et Al. (2021) . "Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology." WORLD JOURNAL OF STEM CELLS , vol.13, no.6, pp.485-502.
@article{article, author={Yunus E. Eksi Et Al. }, title={Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology}, journal={WORLD JOURNAL OF STEM CELLS}, year=2021, pages={485-502} }